Dashboard
Manage Tickers

QDEL


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

g-iii-apparel-posts-upbeat-results-joins-nio-yext-shoe-carnival-and-other-big-stocks-moving-higher-on-thursday
G-III Apparel Posts Upbeat Results, Joins ...
09/05/2024 17:44:24

craig-hallum-upgrades-quidelortho-to-buy-raises-price-target-to-57
Craig-Hallum Upgrades QuidelOrtho to Buy, ...
09/05/2024 16:32:41

Craig-Hallum analyst Alexander Nowak upgrades QuidelOrtho (NASDAQ:QDEL) from Hold to Buy and raises the price target from $4...

quidelortho-has-received-fda-510k-clearance-for-its-vitros-syphilis-assay-using-the-automated-vitros-systems-this-assay-is-intended-for-the-qualitative-determination-of-total-igg-and-igm-antibodies-to-treponema-pallidum-specific-antigens-in-human-serum-and-plasma
QuidelOrtho Has Received FDA 510(k) Cleara...
08/29/2024 11:41:54

 The presence of antibodies to TP-specific antigens, in conjunction with non-treponemal laboratory tests and clinical findings ...

rbc-capital-reiterates-outperform-on-quidelortho-maintains-61-price-target
RBC Capital Reiterates Outperform on Quide...
08/16/2024 16:02:32

RBC Capital analyst Conor McNamara reiterates QuidelOrtho (NASDAQ:QDEL) with a Outperform and maintains $61 price target.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
08/08/2024 17:35:17

rbc-capital-reiterates-outperform-on-quidelortho-maintains-61-price-target
RBC Capital Reiterates Outperform on Quide...
08/01/2024 15:54:02

RBC Capital analyst Conor McNamara reiterates QuidelOrtho (NASDAQ:QDEL) with a Outperform and maintains $61 price target.

quidelortho-q2-2024-adj-eps-007-beats-023-estimate-sales-637000m-beat-613537m-estimate
QuidelOrtho Q2 2024 Adj. EPS $(0.07) Beats...
07/31/2024 20:13:52

QuidelOrtho (NASDAQ:QDEL) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.23) b...

att-group-1-automotive-mattel-seagate-and-other-big-stocks-moving-higher-on-wednesday
AT&T, Group 1 Automotive, Mattel, Seagate ...
07/24/2024 14:46:56

Core News & Articles
QuidelOrtho To Replace Hibbett In S&P Smal...
07/23/2024 21:19:28

JD Sports Fashion Plc (XLON: JD) is acquiring Hibbett in a deal expected to close soon pending final closing conditions. 

Core News & Articles
Avantor To Replace QuidelOrtho In The S&P ...
07/23/2024 21:18:19

activist-jana-partners-built-position-in-quidelortho-in-first-quarter
Activist Jana Partners Built Position In Q...
05/14/2024 16:55:05

- Reuters Citing Sources 

rbc-capital-maintains-outperform-on-quidelortho-lowers-price-target-to-68
RBC Capital Maintains Outperform on Quidel...
05/09/2024 17:08:00

RBC Capital analyst Conor McNamara maintains QuidelOrtho (NASDAQ:QDEL) with a Outperform and lowers the price target from $8...

quidelortho-q1-2024-adj-eps-044-beats-039-estimate-sales-711000m-beat-693244m-estimate
QuidelOrtho Q1 2024 Adj EPS $0.44 Beats $0...
05/08/2024 20:34:21

QuidelOrtho (NASDAQ:QDEL) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.39 by ...

quidelortho-appoints-brian-blaser-as-president-and-ceo-effective-may-6
QuidelOrtho Appoints Brian Blaser As Presi...
05/02/2024 12:19:39

In addition to his appointment as President and CEO, Blaser will join the Board, effective May 15, 2024, when the Board will be...

quidelortho-adds-fentanyl-test-to-its-vitros-systems-as-a-microtip-partnership-assay-to-help-hospital-and-emergency-room-customers-allow-on-site-fentanyl-testing-in-less-than-10-minutes
QuidelOrtho Adds Fentanyl Test To Its Vitr...
04/10/2024 11:09:14

why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Stryve Foods Shares Are Trading Lower ...
04/02/2024 17:23:42

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

whats-going-with-covid-19-test-maker-quidelortho-stock-on-tuesday
What's Going With COVID-19 Test Maker Quid...
04/02/2024 17:05:36

QuidelOrtho secures FDA approval for QuickVue COVID-19 test, catering to home and medical settings. Despite Savanna RVP4+ assay...

rbc-out-with-note-on-quidelortho-saying-after-speaking-to-management-no-change-at-quidelortho-company-withdraws-original-savanna-rvp4-assay-from-fda-510k-submission-plans-resubmission-ahead-of-20242025-respiratory-season
RBC Out With Note On QuidelOrtho Saying "A...
04/02/2024 16:19:09

quidelortho-receives-fda-clearance-for-quickvue-covid-19-test
QuidelOrtho Receives FDA Clearance For Qui...
04/02/2024 13:01:08

Test Delivers on Company Commitment to Advance the Power of Diagnostics to Empower Patients with Rapid Results in Just 10 Minut...

quidelortho-receives-health-canada-approval-for-quidel-triage-plgf-test-for-laboratory-use-in-canada
QuidelOrtho Receives Health Canada Approva...
03/06/2024 21:50:56

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION